PeproMene, IFLI: First FL Patient on BAFF-R CAR-T Sees Complete Response
PeproMene Bio, Inc. (PMB) a clinical-stage biotech company developing novel therapies to treat cancers and immune disorders, today announced that the first r/r FL patient treated...